More women than men have a heart attack without the classic chest pain
The crushing chest pressure is real and common. But in a registry of more than a million patients, 42% of women arrived without chest pain, against 31% of men — and the gap was widest in the young.
| Group | Value (%) |
|---|---|
| Women | 42 |
| Men | 30.7 |
The single most useful thing to know about heart attack symptoms is that the textbook version — sudden crushing pain in the centre of the chest — is common but not universal, and it is absent more often in women than in men. That does not mean women rarely get chest pain; most people of either sex do. It means the odds of a heart attack arriving without it are meaningfully higher for women, and highest in younger women, which is exactly the group least likely to suspect their heart.
What the largest registry showed
The clearest numbers come from the US National Registry of Myocardial Infarction, which recorded 1,143,513 patients hospitalised with a heart attack between 1994 and 2006 — 481,581 women and 661,932 men [s1]. The proportion who presented without chest pain was 42.0% among women and 30.7% among men [s1].
The gap was not fixed across ages. It was widest in the youngest patients and narrowed steadily with age [s1]. Among people younger than 45, women had an adjusted odds ratio of 1.30 for presenting without chest pain relative to men; by age 75 or older the odds ratio had fallen to 1.03, essentially no difference [s1]. In other words, a 40-year-old woman is the person most likely to have a heart attack that does not announce itself the expected way.
That matters because presentation without chest pain tracked with worse outcomes. In the same registry, in-hospital mortality was 14.6% for women and 10.3% for men [s1]. Younger women who presented without chest pain had higher hospital mortality than younger men without chest pain, a difference that shrank and even reversed with advancing age [s1]. Some of that reflects delay: a symptom nobody recognises as cardiac is a symptom nobody acts on quickly.
The symptoms to actually watch for
The American Heart Association's 2016 scientific statement — its first devoted specifically to acute myocardial infarction in women — notes that cardiovascular disease is the leading cause of death in American women, and that sex-specific differences exist in how heart attacks present, not only in who gets them [s2]. It frames the sex difference in symptoms as real but a matter of degree, not a separate disease.
The core warning signs, as summarised by the US National Library of Medicine, are consistent for everyone [s3]:
- Chest discomfort — often in the centre or left side of the chest, usually lasting more than a few minutes, and it may go away and come back [s3].
- Shortness of breath, which is sometimes the only symptom and may come before or during the chest discomfort [s3].
- Discomfort in the upper body — pain or discomfort in one or both arms, the back, shoulders, neck, jaw, or the upper part of the stomach [s3].
Other symptoms can include nausea, vomiting, dizziness, palpitations, lightheadedness, and breaking out in a cold sweat [s3]. The library notes that women sometimes have different symptoms from men — for example, being more likely to feel tired for no reason [s3]. Fatigue, breathlessness, jaw or back discomfort and nausea are easy to attribute to something benign, and that is precisely why they are dangerous when they are cardiac.
What to do
The rule does not change with sex or age. If you or someone else has symptoms of a heart attack, call 911 — even if you are not sure it is a heart attack [s3]. Emergency dispatchers would far rather assess a false alarm than have someone wait at home rationalising symptoms. Do not drive yourself; an ambulance can begin treatment on the way and routes you to the right hospital.
The point of the sex data is not that women should watch for a different checklist. It is that the absence of dramatic chest pain is not reassurance. A heart attack can present as breathlessness, unusual fatigue, or discomfort spreading to the jaw, back or arm — and treating any of those as "probably nothing" is the mistake the mortality figures capture.
The limits
The registry data are observational and now more than a decade old; presentation patterns and in-hospital care have both moved since. They describe populations, not individuals — plenty of women have crushing chest pain, and plenty of men have none. And "without chest pain" is not the same as "without symptoms": most of these patients had warning signs, just not the one everyone is taught to expect.
None of this is medical advice for a particular person. Anyone weighing their own risk, or trying to interpret a symptom, should speak to a clinician who can see the full picture — and anyone with symptoms now should call emergency services rather than read.
Sources
- Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital Mortality — JAMA , February 22, 2012
- Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association — Circulation , March 1, 2016
- Heart Attack — MedlinePlus (US National Library of Medicine)
More on
What is a silent heart attack, and how often does one go unnoticed?
Some heart attacks leave scar on an ECG or MRI but were never felt as one. In a long US cohort they made up more than 45% of heart attacks — and they still shortened survival.
Does cardiac rehabilitation after a heart attack work?
Pooled across 85 trials, exercise-based cardiac rehab cut later heart attacks and hospital admissions but barely moved death rates within a year — a real benefit, and a narrower one than the usual pitch.
Routine CT coronary scans after chest pain did not cut later heart attacks
TARGET-CTCA randomised 3,170 emergency patients whose troponin had cleared them of a heart attack. Outpatient CT angiography-guided care matched standard care on later infarction or cardiac death.
Does the flu shot lower heart-attack risk? Trials point that way
In heart patients, randomised trials link influenza vaccination to fewer cardiovascular events and deaths. The effect is clearest in the highest-risk patients, and the largest trial stopped early.